RecruitingNCT06474533

Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm


Sponsor

Thomas Hope

Enrollment

199 participants

Start Date

Jun 21, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This is a single center study investigating the use of Fluoroethyltyrosine (FET) in the detection of brain tumors. FET accumulates in malignant cells within intracranial neoplasms and can be used to detect recurrent disease and characterize grade of glial neoplasms.


Eligibility

Min Age: 4 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a special type of PET scan (a brain imaging technique) using a tracer called FET (fluoroethyltyrosine) to better evaluate brain tumors. The goal is to see if this scan can more accurately detect whether a brain tumor is growing back after treatment, or help doctors plan surgery or radiation more precisely. **You may be eligible if...** - You are older than 3 years old - You have a brain tumor and are either: being evaluated for possible recurrence after treatment (surgery/radiation), OR being assessed before planned surgery or biopsy - You have a suspected high- or low-grade brain tumor, or brain metastases **You may NOT be eligible if...** - You are unable to undergo PET or MRI/CT scans (e.g., certain metal implants) - You are unlikely to comply with study procedures Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGFluorethyltyrosine (18-F)

Given intravenously (IV)

PROCEDUREPositron Emission Tomography (PET)

Undergo Imaging Procedure


Locations(1)

University of California, San Francisco

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06474533


Related Trials